Related Experiment Video
Updated: Aug 6, 2026

14:37
Modeling an Enzyme Active Site using Molecular Visualization Freeware
Published on: December 25, 2021
Identifying Cryptic Binding Sites with Mixed Solvent MD Simulation and SiteMap
Da Shi1, Dmitry Lupyan2, Steven Jerome3
1Schrödinger Inc., 9868 Scranton Road, Suite 3200, San Diego, California 92121, United States.
Journal of Chemical Information and Modeling
|July 23, 2026
Summary
This study introduces a new method combining mixed solvent molecular dynamics (MxMD) and SiteMap to find hidden protein binding sites. This approach improves drug discovery by revealing cryptic sites for new therapeutic targets.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- Identifying cryptic binding sites in proteins is crucial for structure-based drug discovery but challenging due to their absence in apo structures.
- Existing methods often fail to reveal these transient or hidden pockets, limiting the exploration of potential drug targets.
Purpose of the Study:
- To develop and validate a novel computational workflow for the effective identification of cryptic protein binding sites.
- To enhance early-phase drug discovery by enabling the exploration of previously inaccessible druggable targets.
Main Methods:
- Integration of mixed solvent molecular dynamics (MxMD) simulations with the SiteMap computational tool.
- MxMD was used to sample diverse protein conformations, inducing the exposure of hidden pockets.
- SiteMap was employed to identify and rank these exposed cryptic binding sites.
Main Results:
- The developed "induce-and-identify" workflow successfully identified cryptic binding sites in a challenging dataset of 65 examples.
- The workflow achieved a high success rate, identifying the correct cryptic binding site within the top 5 predictions in 78.5% of cases.
- Demonstrated robustness and effectiveness in revealing previously hidden protein pockets.
Conclusions:
- The combined MxMD + SiteMap workflow is a powerful and reliable tool for structure-based drug discovery.
- This method significantly expands the scope of druggable targets by effectively inducing and identifying cryptic binding sites.
- Facilitates early-phase drug discovery efforts by providing a systematic approach to uncover challenging protein targets.
Related Concept Videos
Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

